Jul 10, 2019
Growing prevalence of HIV across the globe will drive HIV diagnostics industry growth during the forecast period. According to the UNAIDS?s data in 2017, more than 35 million people across the world, were living with HIV.
![]()
Delaware, Selbyville - July 10, 2019 /MarketersMedia/ —
The study on the global market for HIV Diagnostics evaluated the historical and current performance of this market, especially highlighting the key trends and growth opportunities. According to the study, the rising demand for this product is driving the global market for Global HIV Diagnostics significantly. The expansion in the various related industry is also expected to reflect positively on the sales of Global HIV Diagnostics product over the next few years.
HIV Diagnostics Market will exceed USD 5 billion by 2024; as per a new research report.
Growing prevalence of HIV across the globe will drive HIV diagnostics industry growth during the forecast period. According to the UNAIDS?s data in 2017, more than 35 million people across the world, were living with HIV. Additionally, about 1.8 million new cases were diagnosed with HIV infection in 2017. This will surge the demand for HIV diagnostics thereby positively influencing the business growth. Favorable regulatory scenario coupled with fair reimbursement for HIV diagnostics will further spur HIV diagnostics market in the coming years.
Request a sample of this premium report titled at https://www.marketstudyreport.com/request-a-sample/467735/?utm_source=MM-VarsH
Moreover, HIV point of care test (POCT) used to provide quick results and approved for screening will accelerate industry growth. Improved access to HIV tests and associated diagnostics will increase adoption of POCT during forthcoming years. Growing need to combine these technologies efficiently and cost-effectively into existing laboratory networks and clinical algorithms will favor HIV diagnostics business growth. However, low penetration of HIV diagnostics in under-developed or poorly resourced countries due to limited access to lifesaving treatments may impede the industry growth in the foreseeable future.
Antibody tests segment accounted for more than 33% revenue share in 2017 and is expected to show considerable growth over forecast period. The growth is attributable to rising incidences of HIV infection across the globe. Availability of several antibody tests such as rapid and home tests for early HIV detection will further increase its adoption over the coming years. Rising awareness among people regarding regular blood tests and increasing prevalence of HIV symptoms will favor business growth.
Viral load testing segment is projected to experience lucrative CAGR of 9.2% over the forecast period. Growing need for early detection of HIV infection and monitoring treatment progress will fuel viral load testing market growth. Growing technological advancements such as branched DNA (bDNA), nucleic acid sequence-based amplification assay (NASBA) and reverse transcription polymerase chain reaction (RT-PCR) to determine blood HIV viral load will augment the segment growth.
U.S. HIV diagnostics market held the largest revenue in North America valued at USD 876.8 in 2017 and will grow significantly over the forecast timeline. Growth is attributable to increasing prevalence of HIV infection in the country coupled with high awareness among people regarding HIV diagnosis and treatment. Moreover, strong foothold of key industry players in the U.S., and regulatory support coupled with high healthcare expenditure will favor HIV diagnostics business growth.
Request a discount on standard prices of this premium report titled at https://www.marketstudyreport.com/check-for-discount/467735
South Africa HIV diagnostics market is estimated to grow at a lucrative CAGR of 8.8% during the analysis period. High prevalence of AIDS in South African population will offer several growth opportunities for business growth. According to the UNAIDS, more than 7 million people were living with HIV infection in 2017. Initiatives undertaken by various government and non-governmental organizations to create awareness and increase HIV diagnosis in the country will further accelerate industry growth.
Some of the players operating in HIV diagnostics market are Siemens Healthineers, Merck, Sysmex Partec, PointCare Technologies, Alere, Qiagen, Apogee Flow Systems, Cepheid, Roche Diagnostics, Hologic, Beckman Coulter Biomedical, ChemBio Diagnostics, Abbott, Biomerieux and BD Biosciences. Prime focus of the industry players is on inorganic strategies including acquisitions, merger, partnership and new product launch to strengthen their existing product portfolio and maintain market position.
Report Content
Chapter 1. Methodology
1.1. Methodology
1.2. Market definitions
1.3. Forecast parameters
1.4. Data sources
1.4.1. Secondary
1.4.1.1. Paid sources
1.4.1.2. Unpaid sources
1.4.2. Primary
Chapter 2. Executive Summary
2.1. HIV diagnostics industry 360 degree synopsis, 2013 - 2024
2.1.1. Business trends
2.1.2. Product trends
2.1.3. Regional trends
Chapter 3. HIV Diagnostics Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2013 - 2024
3.3. Industry impact forces
3.3.1. Growth drivers
3.3.1.1. Favorable regulatory landscape in the U.S.
3.3.1.2. Point-of-care (POC) HIV diagnostics development
3.3.1.3. Increasing number of blood transfusions and blood donations
3.3.1.4. Rising AIDS/HIV prevalence in low and middle-income countries
3.3.1.5. Increasing government initiatives for HIV awareness
3.3.2. Industry pitfalls and challenges
3.3.2.1. Low degree of penetration in underdeveloped market
3.4. Growth potential analysis
3.4.1. By product
3.5. Regulatory landscape
3.6. Technology landscape
3.6.1. Point of care tests (rapid tests)
3.6.2. Over-the-counter tests (OTC)
3.7. Reimbursement scenario
3.8. Pricing analysis
3.9. Porter's analysis
3.10. Competitive landscape, 2017
3.10.1. Strategy dashboard
3.11. PESTEL analysis
Chapter 4. HIV Diagnostics Market, By Product
4.1. Key segment trends
4.2. Antibody tests
4.2.1. Market size, by region, 2013-2024 (USD Million)
4.2.2. HIV-1 screening tests
4.2.2.1. Market size, by region, 2013-2024 (USD Million)
4.2.2.2. ELISA/EIA
4.2.2.2.1. Market size, by region, 2013-2024 (USD Million)
4.2.2.3. Home access dried blood spot
4.2.2.3.1. Market size, by region, 2013-2024 (USD Million)
4.2.2.4. Rapid tests
4.2.2.4.1. Market size, by region, 2013-2024 (USD Million)
4.2.3. HIV-1 confirmatory tests
4.2.3.1. Market size, by region, 2013-2024 (USD Million)
4.2.3.2. Western blot test
4.2.3.2.1. Market size, by region, 2013-2024 (USD Million)
4.2.3.3. Indirect immunofluorescent antibody assay (IFA)
4.2.3.3.1. Market size, by region, 2013-2024 (USD Million)
4.2.3.4. Line immunoassay (Cnf)
4.2.3.4.1. Market size, by region, 2013-2024 (USD Million)
4.2.3.5. Radioimmunoprecipitation assay (RIPA)
4.2.3.5.1. Market size, by region, 2013-2024 (USD Million)
4.2.4. HIV-2 & Group O diagnostic tests
4.2.4.1. Market size, by region, 2013-2024 (USD Million)
4.2.4.2. Blood antibody test
4.2.4.2.1. Market size, by region, 2013-2024 (USD Million)
4.2.4.3. Dried blood spot (DBS) test
4.2.4.3.1. Market size, by region, 2013-2024 (USD Million)
4.2.4.4. Line immunoassay (HIV-2)
4.2.4.4.1. Market size, by region, 2013-2024 (USD Million)
4.2.4.5. Others
4.2.4.5.1. Market size, by region, 2013-2024 (USD Million)
4.3. Viral identification assays
4.3.1. Market size, by region, 2013-2024 (USD Million)
4.3.2. p24 antigen tests
4.3.2.1. Market size, by region, 2013-2024 (USD Million)
4.3.3. Qualitative PCR tests
4.3.3.1. Market size, by region, 2013-2024 (USD Million)
4.3.4. Viral culture
4.3.4.1. Market size, by region, 2013-2024 (USD Million)
4.4. CD4 testing
4.4.1. Market size, by region, 2013-2024 (USD Million)
4.5. Viral load testing
4.5.1. Market size, by region, 2013-2024 (USD Million)
4.6. Early infant diagnosis
4.6.1. Market size, by region, 2013-2024 (USD Million)
Complete report titled at https://www.marketstudyreport.com/reports/hiv-diagnostics-market
About Us:
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.
Contact Info:
Name: Arun Hegde
Email: Send Email
Organization: Market Study Report
Website: https://www.marketstudyreport.com/
Source: MarketersMedia
Release ID: 88894929
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.